Auris Medical Announces Randomization of First Patient in AM-125 Phase 2 Trial in Acute Vertigo
30 juil. 2019 08h30 HE
|
Auris Medical AG
Hamilton, Bermuda, July 30, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical...